Personalized Tumor RNA Loaded Lipid-Nanoparticles Prime the Systemic and Intratumoral Milieu for Response to Cancer Immunotherapy

Translation of nanoparticles (NPs) into human clinical trials for patients with refractory cancers has lagged due to unknown biologic reactivities of novel NP designs. To overcome these limitations, simple well-characterized mRNA lipid-NPs have been developed as cancer immunotherapeutic vaccines. Wh...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Nano Lett
Main Authors: Sayour, Elias J., Grippin, Adam, Leon, Gabriel De, Stover, Brian, Rahman, Maryam, Karachi, Aida, Wummer, Brandon, Moore, Ginger, Castillo-Caro, Paul, Fredenburg, Kristianna, Sarkisian, Matthew R., Huang, Jianping, Deleyrolle, Loic P., Sahay, Bikash, Carrera-Justiz, Sheila, Mendez-Gomez, Hector R., Mitchell, Duane A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6597257/
https://ncbi.nlm.nih.gov/pubmed/30259750
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acs.nanolett.8b02179
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados